Neuland Laboratories Executive and Leadership Team

Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the overarching corporate strategy and operational execution. Davuluri guides the company's mission to accelerate drug development and cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), applying strong process chemistry expertise within stringent regulatory environments. Overseeing global operations, the Chief Executive Officer & Managing Director ensures alignment with market demands and scientific advancements. This leadership role involves fostering innovation and driving growth across all business units. By optimizing resource allocation and strategic partnerships, Saharsh Davuluri directly impacts Neuland Laboratories' position as a leading end-to-end solution provider for the pharmaceutical industry. Ultimately, Davuluri secures the company's long-term vision and market leadership.

Shashank Mahashabde, the Contract Manufacturing President, Business Development at Neuland Laboratories, spearheads the expansion of the company's contract manufacturing services. Mahashabde drives strategic partnerships and client acquisition, focusing on leveraging Neuland Laboratories' expertise in process chemistry for API development and cGMP manufacturing. Overseeing market outreach and commercial strategy, the Contract Manufacturing President, Business Development identifies and secures new business opportunities within the global pharmaceutical sector. This leadership function is crucial for translating the company's scientific capabilities into revenue growth and enhanced market presence. By fostering strong client relationships and understanding evolving industry needs, Shashank Mahashabde directly contributes to Neuland Laboratories' role as an end-to-end solution provider. Ultimately, Mahashabde ensures the sustained growth and operational success of the contract manufacturing division.

Ajitabh Singh, the Vice President, Information Technology & Chief Information Officer at Neuland Laboratories, architects the company's digital infrastructure and information security. Singh oversees the implementation of advanced IT solutions that support Neuland Laboratories' core competencies in process chemistry and regulatory manufacturing. Driving technological innovation, the Vice President, Information Technology & Chief Information Officer ensures seamless data management and operational efficiency across the organization. This critical role involves safeguarding sensitive intellectual property and enhancing the company's end-to-end service capabilities for the global pharmaceutical sector. By integrating cutting-edge technologies, Ajitabh Singh directly contributes to the acceleration of drug development and the reliability of cGMP manufacturing processes. Ultimately, Singh fortifies Neuland Laboratories' technological foundation for sustained growth and competitive advantage.

Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, orchestrates the strategic market positioning and material flow for the company's API manufacturing operations. Shekar drives the commercialization efforts, ensuring that Neuland Laboratories' advanced process chemistry solutions reach the global pharmaceutical industry effectively. Overseeing market analysis and brand strategy, the Deputy Manager, Material Planning & Chief Marketing Officer identifies new opportunities and strengthens customer relationships. This dual-focused role involves optimizing supply chain logistics for raw materials while simultaneously expanding market reach and brand awareness. By aligning material planning with market demand, Raja Shekar directly enhances the company's ability to deliver reliable drug development and cGMP manufacturing services. Ultimately, Shekar ensures Neuland Laboratories maintains its leadership in providing end-to-end chemistry-related services.

Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, cultivates a high-performance culture essential for scientific innovation and regulatory compliance. Peruvelli directs talent acquisition, development, and retention strategies, ensuring Neuland Laboratories attracts and retains the skilled scientific and technical teams vital for its operations. Driving employee engagement and organizational development, the Chief Human Resources Officer fosters an environment that supports the company's core competence in process chemistry and cGMP manufacturing. This leadership position involves aligning human capital with strategic business objectives, particularly in accelerating drug development and providing end-to-end solutions. By nurturing a robust workforce, Hemchandra Peruvelli directly strengthens Neuland Laboratories' capacity to meet the complex demands of the global pharmaceutical industry. Ultimately, Peruvelli ensures the company's people are its greatest asset in achieving its mission.

Adrian Monk, the Chief Medical Officer at Neuland Laboratories, provides critical medical and scientific oversight for the company's pharmaceutical development services. Monk ensures that all activities related to drug development and API manufacturing align with the highest standards of patient safety and clinical efficacy. Guiding clinical strategy and regulatory affairs, the Chief Medical Officer enhances Neuland Laboratories' reputation for reliability in a highly regulated environment. This role is pivotal in translating strong process chemistry into tangible therapeutic solutions for the global pharmaceutical industry. By offering expert medical insights, Adrian Monk directly supports the acceleration of drug development pipelines and the successful cGMP manufacturing of APIs. Ultimately, Monk reinforces Neuland Laboratories' commitment to advancing healthcare through scientific excellence and rigorous quality control.

Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, shapes the company's brand narrative and market presence. Paul directs strategic communication initiatives, ensuring Neuland Laboratories' leadership in API manufacturing and its end-to-end solution capabilities are clearly articulated to the global pharmaceutical industry. Driving integrated marketing campaigns and public relations, the Chief Marketing & Communications Officer enhances brand visibility and stakeholder engagement. This role is essential for conveying the company's commitment to strong process chemistry, regulatory compliance, and accelerating drug development. By effectively communicating Neuland Laboratories' value proposition, Dorothy Paul directly supports business development and strengthens the company's reputation for excellence. Ultimately, Paul ensures consistent and impactful messaging that reinforces Neuland Laboratories' position as a trusted partner.